Design, synthesis, and in vitro bioactivity evaluation of fluorine-containing analogues for sphingosine-1-phosphate 2 receptor

Add time:07/15/2019    Source:sciencedirect.com

Twenty eight new aryloxybenzene analogues were synthesized and their in vitro binding potencies toward S1PR2 were determined using a [32P]S1P competitive binding assay. Out of these new analogues, three compounds, 28c (IC50 = 29.9 ± 3.9 nM), 28e (IC50 = 14.6 ± 1.5 nM), and 28g (IC50 = 38.5 ± 6.3 nM) exhibited high binding potency toward S1PR2 and high selectivity over the other four receptor subtypes (S1PR1, 3, 4, and 5; IC50 > 1000 nM). Each of the three potent compounds 28c, 28e, and 28g contains a fluorine atom that will allow developing F-18 labeled PET radiotracers for imaging S1PR2.

We also recommend Trading Suppliers and Manufacturers of (R)-tert-Butyl 3-(2-(trifluoromethyl)phenoxy)pyrrolidine-1-carboxylate (cas 960491-88-7). Pls Click Website Link as below: cas 960491-88-7 suppliers

Prev:Investigation of stereoselectivities in the coupling reactions of 1-O-methyl-3, 5-di-O-p-toluoyl-2-deoxyribofuranoside with purines and pyrimidines
Next:Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors)